Navigation Links
HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
Date:12/15/2010

FRAMINGHAM, Mass. and SYDNEY, Dec. 15, 2010 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR, ASX: HIN) ("HeartWare") announced today the completion of a public offering of $143.75 million principal amount of convertible senior notes due 2017 (the "notes"), pursuant to an effective shelf registration statement filed with the Securities and Exchange Commission ("SEC") on December 9, 2010.  This amount includes $18.75 million aggregate principal amount of notes sold pursuant to the underwriters' exercise in full of their option to purchase an additional amount of the notes to cover over-allotments.

The notes will bear interest at a rate of 3.50% per annum and will mature on December 15, 2017.  The notes will be convertible upon the occurrence of certain events and during specified periods.  Upon conversion, HeartWare will pay or deliver, as the case may be, cash, shares of HeartWare's common stock or a combination thereof, at HeartWare's option.

The initial conversion rate will be 10.0000 shares of common stock per $1,000 principal amount of notes, which corresponds to an initial conversion price of $100.00, representing a conversion premium of approximately 23% based on the closing price of $81.31 on December 9, 2010.  The conversion rate is subject to adjustment from time to time upon the occurrence of certain events.  

The Company also announced the completion of a concurrent public offering of 1,000,000 shares of HeartWare's common stock held by Apple Tree Partners I, L.P., one of HeartWare's existing stockholders, at a price per share of $81.31 pursuant to an effective shelf registration statement filed with the SEC on December 9, 2010.  This amount includes 100,000 additional shares of common stock sold pursuant to the underwriters' exercise in full of their option to purchase additional shares of common stock to cover over-allotments.

HeartWare intends to use the net proce
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Presentation of HeartWare Clinical Results
2. HeartWare International Clinical Trial Shows 90% Survival at 180 Days
3. U.S. FDA Authorizes Expansion to 40 Clinical Sites for HeartWare U.S. Bridge-to-Transplant Clinical Trial
4. HeartWare International Reports Third Quarter Revenues of $7.5 Million
5. HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City
6. HeartWare to Present at the UBS 2010 Global Life Sciences Conference
7. HeartWare to Present at Lazard Capital Markets Circulatory Assist Device Day
8. HeartWare to Report Financial Results for Third Quarter of 2010
9. HeartWare International Reports Third Quarter 2010 Revenues of $13.8 Million; Compared to $7.5 Million in Third Quarter of 2009
10. HeartWare Bridge-to-Transplant Data Featured as Late Breaking Clinical Trial at American Heart Association Scientific Sessions 2010
11. HeartWare to Present at the Lazard Capital Markets 7th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 17, 2014  ImmunoCellular Therapeutics, Ltd. ("ImmunoCellular") (NYSE ... Trademark Office (USPTO) has issued a key patent ... immunotherapeutic vaccine targeting six tumor antigens that are ... Patent No. 8,871,211, which issued October 28, 2014, ... a dendritic cell composition comprising peptide epitopes of ...
(Date:12/17/2014)... KENNESAW, Ga. and RALEIGH, ... Clinical Trial Marketing Communications, LLC (CTMC), and Integrated ... in patient recruitment and retention for clinical trials ... called Integrated Clinical Trial Marketing Services (i-CTMS). i-CTMS ... and retention services to pharmaceutical, biotechnology and medical ...
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ... of the "MEMS Gyroscopes Analog Devices ADIS16136 ... report to their offering. ... tactical grade applications made a lot of progress ... reliability. They are now accepted in high-reliability environments, ...
Breaking Medicine Technology:ImmunoCellular Therapeutics Announces Issuance of Key Patent For ICT-107 Cancer Vaccine 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 2Integrated Clinical Trial Services and Clinical Trial Marketing Communications Form Joint Venture 3MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
... 21, 2011 Valeant Pharmaceuticals International, Inc. (NYSE: ... a conference call and a live Internet webcast along with ... a.m. ET (7:00 a.m. PT) to discuss results for the ... on this call is (877) 295-5743, confirmation code ...
... Undy 5000 5K Run/Walk to fight colon cancer is returning to ... place on Saturday, October 29 at 8:30 a.m. at Winfrey Point ... patient advocacy organization, will host the event to help bring greater ... in the United States. "Last year, we had ...
Cached Medicine Technology:Valeant Pharmaceuticals to Announce 2011 Third Quarter Results on November 3, 2011 2Runners Take to the Streets in Undies to Fight Colon Cancer 2Runners Take to the Streets in Undies to Fight Colon Cancer 3
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Greater participation in music ... finds. Researchers followed kids in the nonprofit Harmony ... children in Los Angeles. Over two years, children ... in how the brain processes speech and reading, compared ... the benefits of active participation in music classes occurred ...
(Date:12/17/2014)... Amy Norton HealthDay Reporter ... has long been believed to improve overall health, but a ... help the heart, a new review finds. In fact, ... as brisk walking, said lead researcher Paula Chu, a doctoral ... The review, of 37 clinical trials, found that people randomly ...
(Date:12/15/2014)... 2014 A recent survey found that ... as impacting skin health and beauty were: “Connections,” “climate,” ... care.” Water and health advocate and radio host Sharon ... describing the survey and the Four C’s.* Kleyne notes, ... category discussed would benefit from paying attention to one’s ...
(Date:12/15/2014)... Veretekk.com, Inc. announced today a strategic ... JM Ocean Avenue has secured exclusive benefit to the ... system. JM Ocean Avenue is a direct sales ... Avenue and JM International, with partial ownership coming from ... company. , “After nearly 2 decades of servicing the ...
(Date:12/15/2014)... South Florida’s leading urgent care provider, MD ... daze of hassle, hustle, and bustle that can cause injuries ... burns when making special meals and heartburn after eating them, ... any time. To prevent this season of joy from becoming ... of helpful and healthful holiday tips to keep the season ...
Breaking Medicine News(10 mins):Health News:Music Classes Boost Language Skills, Study Says 2Health News:Yoga May Cut Heart Disease Risk Factors 2Health News:Yoga May Cut Heart Disease Risk Factors 3Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 2Health News:Water and health advocate Sharon Kleyne adds a “W” for fresh water to “four C’s of skin care” 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 2Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 3Health News:JM Ocean Avenue secures the strategic advantages of Veretekk 4Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3
... for active tuberculosis (TB) disease, according to a new study ... data from nearly 17,000 individuals in Taiwan as part of ... studies have reported increased mortality among TB patients who smoke, ... of smoking on active TB incidence using a longitudinal design ...
... The American Gastroenterological Association (AGA) Foundation for Digestive Health ... Edythe Broad Foundation has agreed to renew its three-year ... potential for careers in digestive disease research. The Student ... more than a decade ago to stimulate interest in ...
... diagnosis of Idiopathic Pulmonary Fibrosis is not much better ... the survival rate is less than three years. ... that targeting of a novel gene utilizing genetic and ... mice and will be developed for future testing in ...
... when children get overwhelmed, experts say , SUNDAY, Aug. ... the new school year can relax by practicing "mindfulness" ... University, in Durham, N.C., recommend mindfulness, which is a ... the new school year and deal with many academic ...
... The GaitAid ... from the first step. , ... Washington, DC (PRWEB) August 23, 2009 -- Freezing of Gait (FOG) is an often incapacitating ... their feet are glued to the floor. Will power to keep moving has no effect, ...
... , , , LOUISVILLE, Ky., ... Veterans Affairs (VA) says The American Legion and colleague veterans service ... veterans. Dr. Jan Kemp, the VA,s national suicide prevention coordinator, in ... "We,re failing them. It,s all of our responsibility to own ...
Cached Medicine News:Health News:Smoking increases risk of developing active TB 2Health News:Smoking increases risk of developing active TB 3Health News:The Eli and Edythe Broad Foundation recommit to gastroenterology's future 2Health News:U-M researchers discover therapeutic target that could help patients with pulmonary fibrosis 2Health News:Soothe Back-to-School Anxiety, Teach Kids to Relax 2Health News:At last! A Remarkable Breakthrough for Parkinson's Disease Freezing: The GaitAid Virtual Walker 2Health News:At last! A Remarkable Breakthrough for Parkinson's Disease Freezing: The GaitAid Virtual Walker 3Health News:The American Legion Can Play Key Role in Vets' Suicide Prevention, Says VA 2
... connection of two state-of-the-art progressive scan digital ... beamsplitter on your microscope. The c-mount digital ... firewire cards and receive their power directly ... optical visualization without interference or compromise. The ...
Sony DSR-20MD is the right choice If you need digital recording capability. It accepts both s-video and composite inputs....
... monitoring of oxygen and carbon dioxide, originally ... in a number of different applications, including ... medicine and orthopedic surgery. TcpO2 measurements usually ... to provide a good picture. The more ...
Derrico Perforator Drill and Enlarging Burr...
Medicine Products: